Financial Solutions Advisory Group Inc. acquired a new stake in The Clorox Company (NYSE:CLX – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 9,285 shares of the company’s stock, valued at approximately $962,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Ipsen Advisor Group LLC raised its stake in Clorox by 15.6% in the 1st quarter. Ipsen Advisor Group LLC now owns 4,693 shares of the company’s stock valued at $486,000 after acquiring an additional 635 shares during the period. Carlson Capital L.P. boosted its position in Clorox by 122.8% during the first quarter. Carlson Capital L.P. now owns 18,050 shares of the company’s stock worth $1,871,000 after purchasing an additional 9,950 shares during the period. Alpine Woods Capital Investors LLC increased its holdings in shares of Clorox by 962.5% in the first quarter. Alpine Woods Capital Investors LLC now owns 32,067 shares of the company’s stock valued at $3,323,000 after purchasing an additional 29,049 shares during the last quarter. Essential Partners LLC increased its holdings in shares of Clorox by 558.2% in the first quarter. Essential Partners LLC now owns 441 shares of the company’s stock valued at $46,000 after purchasing an additional 374 shares during the last quarter. Finally, Groupe la Francaise raised its position in shares of Clorox by 13.6% in the first quarter. Groupe la Francaise now owns 54,468 shares of the company’s stock valued at $5,645,000 after purchasing an additional 6,514 shares during the period. 78.53% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages recently commented on CLX. Wells Fargo & Company reduced their target price on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a report on Monday, May 18th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $94.00 price target on shares of Clorox in a report on Wednesday, July 22nd. Barclays boosted their price objective on Clorox from $85.00 to $86.00 and gave the stock an “underweight” rating in a report on Tuesday, July 21st. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $83.00 target price on shares of Clorox in a research report on Friday, May 1st. Finally, Morgan Stanley lowered their target price on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. Twelve equities research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average target price of $101.00.
Insider Transactions at Clorox
In related news, Director Pierre R. Breber acquired 5,000 shares of the stock in a transaction on Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the purchase, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.63% of the stock is owned by corporate insiders.
Clorox Stock Performance
Shares of NYSE:CLX opened at $95.66 on Friday. The company’s 50 day moving average price is $95.51 and its two-hundred day moving average price is $103.67. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $128.90. The firm has a market cap of $11.57 billion, a PE ratio of 15.53 and a beta of 0.54. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03.
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business’s revenue for the quarter was up .1% on a year-over-year basis. During the same period last year, the firm earned $1.45 earnings per share. Equities research analysts predict that The Clorox Company will post 5.52 earnings per share for the current year.
Clorox Company Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Further Reading
- Five stocks we like better than Clorox
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
